- Rating
- 3
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper studies the problem of optimizing existing peptides to make them have constrained, localized chemical modifications, with the primary focus on hydrocarbon stapling. For each peptide, this method constructs a finite intervention space and maps each modification to a canonical product. The experimental results show that the proposed method can actually make accurate modifications to the peptide leads.
Critical strengths
- I find that improving original peptides by adding chemical modifications is a really important application question.
- The evaluation and experimental results can support the claims, and the comparison also helps find the benefits of each part of the method.
Critical weaknesses
- The number of evaluated peptides is relatively small, only 77 test peptides, which limits the strength of the method.
- Also, there are only a few baselines; for example, I would like to see more comparisons with a broader set of peptide optimization or constrained selection methods.
Questions for authors
- How diverse are the test peptides in terms of sequence, length, and receptor structures? Are the improvements distributed across different samples, or are the concentrations in a small subset of peptides that are similar to each other?
- Can the authors explain the motivation for including current baselines? I think you could include more peptide optimization or constrained selection methods.
3 comments
Response to Q2: Baseline Motivation and Extended Comparisons
We appreciate the suggestion to broaden our baseline comparisons. Our original baselines were designed to isolate distinct methodological components under identical chemical, geometric, and editing constraints. We have additionally evaluated an established cyclic-peptide design framework.
1. Motivation for the existing baselines.
Each baseline addresses a specific methodological question:
- Random Feasible: Tests whether uniform selection within the chemically feasible intervention space is sufficient.
- Empirical Reference: Tests whether population-level staple preferences alone can guide effective intervention selection.
- Generic-SB: Evaluates bridge-based optimization without explicit intervention-level control.
- Direct Plan Ranker (DPR): Isolates the contribution of exact distribution-level supervision beyond matched plan representations and input features.
Together, these baselines distinguish the contributions of feasible intervention selection, empirical reference preferences, structured control, and distribution-level supervision.
2. Additional comparison with CP-Composer.
To extend our evaluation beyond matched intervention-selection baselines, we additionally compared StapleBridge with CP-Composer (Jiang et al., 2025), an established zero-shot cyclic-peptide design framework that uses composable geometric constraints for cyclization.
Since CP-Composer's native stapling chemistry uses K–D/E lactam linkages rather than S5/R8 hydrocarbon staples, we introduced a task-compatible HC Adapter while retaining its released pretrained model without retraining. The adapter translates CP-Composer's structural proposals into hydrocarbon-stapling interventions, which are constructed and evaluated under the same chemical feasibility constraints and property-evaluation protocol as StapleBridge. We evaluated CP-Composer + HC Adapter on all 53 hard-supported test peptides across three seeds.
Table R1. Comparison with CP-Composer under the common hydrocarbon-stapling protocol.
| Method | Permeability Improved ↑ | Mean ΔPermeability ↑ | Plan Regret ↓ |
|---|---|---|---|
| CP-Composer + HC Adapter | 73.58 ± 3.77% | 0.1283 ± 0.0046 | 0.8467 ± 0.0389 |
| StapleBridge | 81.13 ± 0.00% | 0.1690 ± 0.0044 | 0.2092 ± 0.0062 |
StapleBridge achieves a 7.55-percentage-point higher improvement rate and a 31.7% larger mean predicted permeability gain, together with 75.3% lower Plan Regret. These results support the effectiveness of lead-specific intervention optimization compared with an adapted zero-shot geometry-guided cyclic-peptide design baseline under a common hydrocarbon-stapling evaluation protocol.
Overall, the additional diversity analyses and broader baseline comparisons strengthen the evidence for StapleBridge's generalization across peptide contexts and the practical value of lead-specific intervention control.
We thank the reviewer again for the constructive feedback, which has helped us improve the evaluation and presentation of our work.
I appreciate the authors’ response and their careful answers to my questions.
Dear Reviewer uvie,
Thank you for your positive assessment of StapleBridge, particularly your recognition of the importance of peptide lead optimization and the comprehensiveness of our evaluation. We appreciate your constructive suggestions and have conducted additional analyses and baseline comparisons to address both concerns.
Response to Q1: Test-Set Diversity and Distribution of Improvements
To assess test-set diversity and whether improvements are broadly distributed, we conducted additional analyses of peptide sequences, receptor structures, and per-peptide performance.
1. Sequence and receptor diversity.
The 77 test peptides comprise 77 unique sequences spanning 5–21 residues (median length: 11). The fixed 53-peptide hard-supported subset forms 44 sequence clusters at 30% global identity and 53 clusters at 50% identity, indicating substantial sequence diversity. The test set also contains 77 distinct receptor sequences, with no receptor pairs exceeding 30% whole-chain sequence identity under our alignment protocol. These receptors span helix-rich, sheet-rich, and mixed secondary-structure classes.
Furthermore, as detailed in Appendix A, our benchmark construction incorporates receptor-homology-aware splitting at 40% sequence identity, excluding development examples sharing receptor clusters with the LNR test set.
2. Distribution and robustness of improvements.
StapleBridge improves predicted permeability for 43/53 supported peptides (81.1%), with improvements distributed across peptide lengths: 9/14 (5–9 residues), 16/19 (10–14 residues), and 18/20 (15–21 residues). Consistent improvements are also observed across receptor structural classes: 19/22 helix-rich, 16/20 mixed, and 8/11 sheet-rich receptors.
To assess whether the average improvement is dominated by a few exceptional cases, we excluded the ten peptides with the largest positive gains. The remaining 43 peptides still achieve a mean predicted permeability improvement of +0.0953 over their linear parents.
These results indicate that StapleBridge's improvements extend across diverse peptide and receptor contexts rather than being concentrated in a small subset of closely related examples. We have also added a test-set diversity analysis and corresponding visualizations to Appendix A, including peptide-length distributions, pairwise sequence identities, and receptor sequence diversity.